Investigación multidisciplinar y traslacional en enfermedades raras

Investigación multidisciplinar y traslacional en enfermedades raras

Dentro de las enfermedades raras, las enfermedades hereditarias constituyen un grupo mayoritario que incluye las ocasionadas por mutaciones en un solo gen (monogénicas) o aquellas ocasionadas por más de un gen (poligénicas). Descubrir que un determinado gen se asocia con el desarrollo de una patolog...

Saved in:
Journal Title: Arbor
First author: Santiago Rodríguez de Córdoba
Other Authors: Carmelo Bernabéu
Palabras clave:
Traslated keyword:
Language: Spanish
Get full text: http://arbor.revistas.csic.es/index.php/arbor/article/view/2281
Resource type: Journal Article
Source: Arbor; Vol 194, No 789 (Year 2018).
DOI:
Publisher: Consejo Superior de Investigaciones Científicas CSIC
Usage rights: Reconocimiento (by)
Categories: Social Sciences/Humanities --> Humanities, Multidisciplinary
Bibliography: Abdalla, S. A. y Letarte, M. (2006). Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. Journal of Medical Genetics, 43 (2), pp. 97-110. https://doi.org/10.1136/jmg.2005.030833 PMid:15879500 PMCid:PMC2603035

Albiñana, V., Bernabeu-Herrero, M. E., Zarrabeitia, R., Bernabéu, C. y Botella, L. M. (2010). Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells. Thrombosis and Haemostasis, 103 (3), 525-534.

Ariceta, G., Besbas, N., Johnson, S., Karpman, D., Landau, D., Licht, C. […] y Zimmerhackl, L. B. (2009). Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatric Nephrology. 24 (4), pp. 687-696. https://doi.org/10.1007/s00467-008-0964-1 PMid:18800230

Atkinson, J. P., Liszewski, M. K., Richards, A., Kavanagh, D. y Moulton, E. A. (2005). Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue. Annals of the New York Academy of Sciences, 1056 (1), pp. 144-155. https://doi.org/10.1196/annals.1352.032 PMid:16387683

Botella, L. M., Sánchez-Elsner, T., Sanz-Rodríguez, F., Kojima, S., Shimada, J., Guerrero-Esteo, M. […] y Bernabéu, C. (2002). Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood, 100 (12), pp. 4001-4010. https://doi.org/10.1182/blood.V100.12.4001

Bourdeau, A., Dumont, D. J. y Letarte, M. (1999). A murine model of hereditary hemorrhagic telangiectasia. The Journal of Clinical Investigation, 104 (10), pp. 1343-1351. https://doi.org/10.1172/JCI8088 PMid:10562296 PMCid:PMC409846

Campistol, J. M., Arias, M., Ariceta, G., Blasco, M., Espinosa, M., Grinyó, J. M. […] y Rodríguez de Córdoba, S. (2013). An update for atypical haemolytic uraemic síndrome: diagnosis and treatment. A consensus document. Nefrología, 33 (1), pp. 27-45. PMid:23364625

Dragon-Durey, M.-A., Loirat, C., Cloarec, S., Macher, M. A., Blouin, J., Nivet, H. [...] y Frémeaux-Bacchi, V. (2005). Anti-Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology, 16 (2), pp. 555-563. https://doi.org/10.1681/ASN.2004050380 PMid:15590760

Dupuis-Girod, S., Ginon, I., Saurin, J. C., Marion, D., Guillot, E., Decullier, E. […] y Faure, F. (2012). Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA, 307 (9), pp. 948-955. https://doi.org/10.1001/jama.2012.250

Fakhouri, F., Hourmant, M., Campistol, J. M., Cataland, S., Espinosa, M., Gaber, O. […] y Legendre, C. M. (2013). Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Adult Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts). Journal of the American Society of Nephrology, 24, pp. 49-50A.

Faughnan, M. E., Palda, V. A., Garcia- Tsao, G., Geisthoff, U. W., McDonald, J., Proctor, D. D. […] y Zarrabeitia, R. (2011). International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. Journal of Medical Genetics, 48 (2), pp.73-87. https://doi.org/10.1136/jmg.2009.069013 PMid:19553198

Greenbaum L. A., Fila M., Tsimaratos M, Ardissimo, G., Al-Akash, S., Evans, J. […] y Licht, C. (2013). Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Pediatric Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts). Journal of the American Society of Nephrology, 24, 821A.

Holers, V. M. (2008). The spectrum of complement alternative pathway-mediated diseases. Immunological Reviews, 223 (1), pp. 300-316. https://doi.org/10.1111/j.1600-065X.2008.00641.x PMid:18613844

Jerkic, M., Rodríguez-Barbero, A., Prieto, M., Toporsian, M., Pericacho, M., Rivas-Elena, J. V. […] y López-Novoa, J. M. (2006). Reduced angiogenic responses in adult Endoglin heterozygous mice. Cardiovascular Research, 69 (4), pp. 845- 854. https://doi.org/10.1016/j.cardiores.2005.11.020 PMid:16405930

Lacombe, P., Lacout, A., Marcy, P. Y., Binsse, S., Sellier, J., Bensalah, M. […] y El-Hajjam, M. (2013). Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview. Diagnostic Interventional Imaging, 94 (9), pp. 835-848. https://doi.org/10.1016/j.diii.2013.03.014 PMid:23763987

Lastres, P., Letamendía, A., Zhang, H., Rius, C., Almendro, N., Raab, U. […] y Bernabéu, C. (1996). Endoglin modulates cellular responses to TGF-beta 1. The Journal of Cell Biology, 133 (5), pp. 1109-1115. https://doi.org/10.1083/jcb.133.5.1109

Lebrin, F., Srun, S., Raymond, K., Martin, S., Brink, S. van den, Freitas, C. […] y Mummery, C. (2010). Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nature Medicine, 16 (4), pp. 420-428. https://doi.org/10.1038/nm.2131 PMid:20364125

Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C. [...] y Loirat, C. (2013). Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. The New England Journal of Medicine, 368 (23), pp. 2169-2181. https://doi.org/10.1056/NEJMoa1208981 PMid:23738544

Lemaire, M., Frémeaux-Bacchi, V., Schaefer, F., Choi, M., Tang, W. H., Quintrec, M. Le [...] y Lifton, R. P. (2013). Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nature Genetics, 45 (5), pp. 531-536. https://doi.org/10.1038/ng.2590 PMid:23542698 PMCid:PMC3719402

Llorca, O., Trujillo, A., Blanco, F. J. y Bernabéu, C. (2007). Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. Journal of Molecular Biology, 365 (3), pp. 694-705. https://doi.org/10.1016/j.jmb.2006.10.015 PMid:17081563

López-Novoa, J. M. y Bernabéu, C. (2010). The physiological role of endoglin in the cardiovascular system. American Journal of Physiology-Heart and Circulatory Physiology, 299 (4), H959-H974. https://doi.org/10.1152/ajpheart.01251.2009 PMid:20656886

Mahmoud, M., Upton, P. D. y Arthur, H. M. (2011). Angiogenesis regulation by TGF? signalling: clues from an inherited vascular disease. Biochemical Society Transactions, 39 (6), pp. 1659-1666. https://doi.org/10.1042/BST20110664 PMid:22103504

Noris, M. y Remuzzi, G. (2009). Atypical hemolytic-uremic syndrome. The New England Journal of Medicine, 361 (17), pp. 1676-1687. https://doi.org/10.1056/NEJMra0902814 PMid:19846853

Repetto, H. A., Rodríguez de Córdoba, S., Arrizurieta, E., Rivas, M. e Ibarra, C. (2008). Microangiopatía trombótica y Síndrome Urémico Hemolítico. En: Hernando Avenda-o, L. (ed.). Nefrología Clínica (3.ª ed.), pp. 286-297. PMCid:PMC5469964

Ricklin, D., Hajishengallis, G., Yang, K. y Lambris, J. D. (2010). Complement: a key system for immune surveillance and homeostasis. Nature Immunology, 11 (9), pp. 785-797. https://doi.org/10.1038/ni.1923 PMid:20720586 PMCid:PMC2924908

Rodríguez de Córdoba, S., Esparza Gordillo, J., Goicoechea de Jorge, E., López-Trascasa, M. y Sánchez-Corral, P. (2004). The human complement factor H: functional roles, genetic variations and disease associations. Molecular Immunology, 41 (4), pp. 355-367. https://doi.org/10.1016/j.molimm.2004.02.005 PMid:15163532

Rodríguez de Córdoba, S., Subías-Hidalgo, M., Pinto, S. y Tortajada, A. (2014). Genetics of atypical Hemolytic Uremic Syndrome (aHUS). Seminars in Thrombosis and Hemostasis, 40, pp. 422-430. https://doi.org/10.1055/s-0034-1375296 PMid:24799305

Rodríguez de Córdoba, S., Tortajada, A., Harris, C. L. y Morgan, B. P. (2012). Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology, 217 (11), pp. 1034-1046. https://doi.org/10.1016/j.imbio.2012.07.021 PMid:22964229

Rossi, E., Sanz-Rodríguez, F., Eleno, N., Düwell, A., Blanco, F. J., Langa, C. […] y Bernabéu, C. (2013). Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. Blood. 121 (2), pp. 403-415. https://doi.org/10.1182/blood-2012-06-435347 PMid:23074273

Shovlin, C. L, Guttmacher, A. E., Buscarini, E., Faughnan, M. E., Hyland, R. H., Westermann, C. J. […] y Plauchu, H. (2000). Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler- Weber syndrome). American Journal of Medical Genetics, 91 (1), pp. 66-67. https://doi.org/10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P

Shovlin, C. L. (2010). Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Reviews, 24 (6), pp. 203-219. https://doi.org/10.1016/j.blre.2010.07.001 PMid:20870325

Srinivasan, S., Hanes, M. A., Dickens, T., Porteous, M. E., Oh, S. P., Hale, L. P. y Marchuk, D. A. (2003). A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Human Molecular Genetics, 12 (5), pp. 473-482. https://doi.org/10.1093/hmg/ddg050

Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M. […] y Goodship, J. (1998). Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney International, 53 (4), pp. 836-844. https://doi.org/10.1111/j.1523-1755.1998.00824.x PMid:9551389

Wooderchak-Donahue, W. L., McDonald, J., O'Fallon, B., Upton, P. D., Li, W., Roman, B. L. […] y Bayrak-Toydemir, P. (2013). BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. The American Journal of Human Genetics, 93 (3), pp. 530-537. https://doi.org/10.1016/j.ajhg.2013.07.004 PMid:23972370 PMCid:PMC3769931